BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37093406)

  • 1. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
    Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
    J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
    Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
    Front Immunol; 2022; 13():882589. PubMed ID: 35479073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
    Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
    Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Yin Q; Wang J; Wang Z
    Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
    Li Y; Li S; Lu N; Wang W; Wang D
    Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
    Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
    Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
    Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
    Liu JH; Liu W; Li YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
    Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
    Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
    Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
    Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
    Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H
    J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analyses of 80 hemophagocytic lymphohistiocytosis patients with Epstein-Barr viremia].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Li S; Tang R; Huang W; Chen J; Pei R; Wang Z
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(36):2841-3. PubMed ID: 25534103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
    Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
    J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China.
    Shao X; Xu Y; Xu X; Xu Y; Chen H; Hong M; Liu L
    Isr Med Assoc J; 2018 Feb; 20(2):80-85. PubMed ID: 29431300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression Profile and Clinical Significance of Cytokines and Chemokines in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis].
    Gao Y; Zheng Y; Zhang WH; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):268-273. PubMed ID: 36765510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study.
    Kong Q; Li M; Wang J; Wu L; Zhou D; Yang M; Xu X; Tan Z; Wu X; Wang Z
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30772. PubMed ID: 37974392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases.
    Miao Y; Zhang J; Chen Q; Xing L; Qiu T; Zhu H; Wang L; Fan L; Xu W; Li J
    Front Immunol; 2022; 13():970183. PubMed ID: 36032133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.